169 related articles for article (PubMed ID: 23204869)
1. Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells.
Thamilselvan V; Menon M; Thamilselvan S
Cancer Manag Res; 2012; 4():383-95. PubMed ID: 23204869
[TBL] [Abstract][Full Text] [Related]
2. Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
Thamilselvan V; Menon M; Thamilselvan S
Int J Cancer; 2016 Oct; 139(7):1632-47. PubMed ID: 27198552
[TBL] [Abstract][Full Text] [Related]
3. Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells.
Thamilselvan V; Menon M; Stein GS; Valeriote F; Thamilselvan S
J Cell Biochem; 2017 Dec; 118(12):4331-4340. PubMed ID: 28430389
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.
Kandaş NO; Randolph C; Bosland MC
Nutr Cancer; 2009; 61(2):251-64. PubMed ID: 19235042
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
Li GX; Hu H; Jiang C; Schuster T; Lü J
Int J Cancer; 2007 May; 120(9):2034-43. PubMed ID: 17230520
[TBL] [Abstract][Full Text] [Related]
6. Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells.
Jiang C; Hu H; Malewicz B; Wang Z; Lü J
Mol Cancer Ther; 2004 Jul; 3(7):877-84. PubMed ID: 15252149
[TBL] [Abstract][Full Text] [Related]
7. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing.
Husbeck B; Peehl DM; Knox SJ
Free Radic Biol Med; 2005 Jan; 38(1):50-7. PubMed ID: 15589371
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitization of carmustine with maitake beta-glucan on androgen-independent prostatic cancer cells: involvement of glyoxalase I.
Finkelstein MP; Aynehchi S; Samadi AA; Drinis S; Choudhury MS; Tazaki H; Konno S
J Altern Complement Med; 2002 Oct; 8(5):573-80. PubMed ID: 12470438
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line.
Freitas M; Alves V; Sarmento-Ribeiro AB; Mota-Pinto A
Biochem Biophys Res Commun; 2011 May; 408(4):713-9. PubMed ID: 21549092
[TBL] [Abstract][Full Text] [Related]
11. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lü J
Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
[TBL] [Abstract][Full Text] [Related]
13. Combined N-terminal androgen receptor and autophagy inhibition increases the antitumor effect in enzalutamide sensitive and enzalutamide resistant prostate cancer cells.
Kranzbühler B; Salemi S; Mortezavi A; Sulser T; Eberli D
Prostate; 2019 Feb; 79(2):206-214. PubMed ID: 30345525
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
Husbeck B; Bhattacharyya RS; Feldman D; Knox SJ
Mol Cancer Ther; 2006 Aug; 5(8):2078-85. PubMed ID: 16928829
[TBL] [Abstract][Full Text] [Related]
15. Inorganic Selenium Induces Nonapoptotic Programmed Cell Death in PC-3 Prostate Cancer Cells Associated with Inhibition of Glycolysis.
Cui J; Yan M; Liu X; Yin S; Lu S; Fan L; Hu H
J Agric Food Chem; 2019 Sep; 67(38):10637-10645. PubMed ID: 31513389
[TBL] [Abstract][Full Text] [Related]
16. Selenium effects on prostate cell growth.
Menter DG; Sabichi AL; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1171-82. PubMed ID: 11097224
[TBL] [Abstract][Full Text] [Related]
17. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
Tian J; Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):230-6. PubMed ID: 20615620
[TBL] [Abstract][Full Text] [Related]
18. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
19. Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.
Marrocco DL; Tilley WD; Bianco-Miotto T; Evdokiou A; Scher HI; Rifkind RA; Marks PA; Richon VM; Butler LM
Mol Cancer Ther; 2007 Jan; 6(1):51-60. PubMed ID: 17218635
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of Docetaxel-Induced Cytotoxicity in Human PC-3 Androgen-Independent Prostate Cancer Cells by Combination With Four Natural Apoptosis-Inducing Anticancer Compounds.
Ahmed IA; Hafiz S; van Ginkel S; Pondugula SR; Abdelhaffez AS; Sayyed HG; El-Aziz EAA; Mansour MM
Nat Prod Commun; 2023 May; 18(5):. PubMed ID: 37292146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]